Pubblicazioni scientifiche
La presenza di AuraSTOP nelle pubblicazioni scientifiche
Aurastop nel trattamento dell’emicrania con aura
(Zavarise P., et al. A combination of Tanacetum parthenium, Griffonia simplicifolia and magnesium (Aurastop) as symptomatic acutre treatment for migraine aura: a retrospective cohort study. Open Access Library Journal. 2917;4,e3660)
(Zavarise P., et al. Combination of Tanacethum Partenium, 5-Hydrossitriptophan (5-Http) and Magnesium in the Prophylaxis of Episodic Migraine without Aura (AURASTOP®) An Observational Study. Internation Journal of Neurology and Braind Disorders. 2017;4(3):1-4)
(Ferrare P., et a. tanacetum, Parthenium, Griffonia Simplicifolia and Magnesium as symptomatic and prophylactic treatment for headache in paediatric patients. International Journal of Neurology and Braind Disorders. ISSN 2377-1348).
(Mainardi F., et al. Efficacy of a combination of tanacetum parthenium, 5-hydroxy tryptohan and magnesium (Aurastop) in episodic migraine prevention: a multicentric observational study. Open Access Library Journal. 2018;5,e4765).
(Dalla Volta G., et al. Comparison of the Effect of Tanacethum Parthenium, 5-Hydroxy tryptophan, and magnesium (Aurastop) versus Magnesium alone on aura phenomenon and its evolution. Pain research and management. 2019;6320163)
(Dalla Volta G., et al. Efficacy of a combination of tanacetum parthenium, 5-hydroxy triptohan and magnesium (Aurastop) in the prevention of high frequency migraine with aura. Open Access Library. 2018;5,e4939)
